cisapride has been researched along with Gastroduodenal Ulcer in 5 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of cisapride, 10 mg three times daily, was evaluated in a double-blind randomized study in 118 patients with non-ulcer dyspepsia." | 9.06 | Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. ( Rösch, W, 1987) |
| "Therefore, we diagnosed bronchial asthma associated with reflux esophagitis and gastroduodenal ulcer." | 5.29 | [A case of bronchial asthma associated with reflux esophagitis, whose peak expiratory flow rate improved with omeprazole and cisapride]. ( Arakawa, M; Fujimori, K; Suzuki, E, 1994) |
| "The effect of cisapride, 10 mg three times daily, was evaluated in a double-blind randomized study in 118 patients with non-ulcer dyspepsia." | 5.06 | Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. ( Rösch, W, 1987) |
| "Dyspepsia affects one in four Australians; of those who present in general practice, the majority will have functional or non-ulcer dyspepsia, with no structural explanation for their symptoms." | 2.39 | Modern management of dyspepsia. ( Talley, NJ, 1996) |
| "Therefore, we diagnosed bronchial asthma associated with reflux esophagitis and gastroduodenal ulcer." | 1.29 | [A case of bronchial asthma associated with reflux esophagitis, whose peak expiratory flow rate improved with omeprazole and cisapride]. ( Arakawa, M; Fujimori, K; Suzuki, E, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, K | 1 |
| Suzuki, E | 1 |
| Arakawa, M | 1 |
| Talley, NJ | 1 |
| Demling, L | 1 |
| Rösch, W | 1 |
| Lederer, PC | 1 |
| Lux, G | 1 |
1 review available for cisapride and Gastroduodenal Ulcer
| Article | Year |
|---|---|
Modern management of dyspepsia.
Topics: Adult; Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Child; C | 1996 |
1 trial available for cisapride and Gastroduodenal Ulcer
| Article | Year |
|---|---|
Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial.
Topics: Cisapride; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Humans; Peptic Ulcer; Piperidin | 1987 |
3 other studies available for cisapride and Gastroduodenal Ulcer
| Article | Year |
|---|---|
[A case of bronchial asthma associated with reflux esophagitis, whose peak expiratory flow rate improved with omeprazole and cisapride].
Topics: Asthma; Cisapride; Esophagitis, Peptic; Humans; Male; Middle Aged; Omeprazole; Peak Expiratory Flow | 1994 |
[A drive substance for the motor in digestion. Introduction].
Topics: Acetylcholine; Cisapride; Dyspepsia; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Mot | 1990 |
[Drugs modifying motility in ulcer therapy].
Topics: Cisapride; Gastrointestinal Motility; Humans; Metoclopramide; Peptic Ulcer; Piperidines; Pirenzepine | 1987 |